Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6987701 | 0.82 | METAP1 (0.46) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL61275 | 0.82 | METAP1 (0.46) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL17590498 | 0.82 | METAP1 (0.46) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL13582 | 0.80 | METAP1 (0.49) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL931400 | 0.80 | METAP1 (0.49) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL12631267 | 0.79 | MAPT (0.49) | HPGDCYP1A2 | |
| SCHEMBL13076173 | 0.79 | METAP1 (0.43) | METAP1METAP2HPGDSIGMAR1CYP1A2 | |
| SCHEMBL13213986 | 0.77 | CA1 (0.50) | HPGD | |
| SCHEMBL13198704 | 0.77 | CA1 (0.50) | HPGD | |
| SCHEMBL13235676 | 0.77 | CTSK (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100168175-A1 | ATPENINS | BAYER CROPSCIENCE AG (DE) | 2010-07-01 | — | — | US | disclosed |
| US-20100168175-A1 | ATPENINS | BAYER CROPSCIENCE AG (DE) | 2010-07-01 | — | — | US | disclosed |
| WO-2010069495-A1 | ATPENINS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168175-A1 | ATPENINS | ATP5ME, ATP5MK, ATP5F1B | METAP1 2709/4885METAP2 1833/4885HPGD 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.